Transplanting microglia derived from human stem cells into mice reveals new possibilities for treating neurodegenerative eye diseases.

Researchers from the Center for Regenerative Medicine (CReM) and the Department of Medicine at Boston Medical Center (BMC) ...

The skin organoid was produced using induced pluripotent stem cells (iPSC’s) from the KOLF cell line, generated by the Human Induced Pluripotent Stem Cell Initiative (HipSci). Find out more ...

Axol Bioscience Ltd. (Axol), a leading induced pluripotent stem cell (iPSC) technology provider for drug discovery, today announced it has fully acquired Phenocell SAS, a pioneer in iPSC-based ...

Century Therapeutics (NASDAQ: IPSC) is harnessing the power of adult stem cells to ... polymyositis in which the immune system attacks muscle and frequently the lungs, skin, joints, and ...

The patients donated their skin cells upon diagnosis while they were ... Modeling Lewy body disease with SNCA triplication iPSC-derived cortical organoids and identifying therapeutic drugs ...

Successes across the de-extinction pipeline signal that the thylacine project is on track as Colossal continues its global effort to fight the extinction crisis. Today Colossal, the de-extinction ...

a pioneer in iPSC-based products and bioassays for skin and retinal disorders. All cancer mutations that cause drug resistance fall into one of four categories. New research has detailed each type ...

The new kind of cell is called an induced pluripotent stem cell or iPSC. It’s made by scientists transforming ordinary skin cells back into embryonic-like stem cells, after which they can be coaxed ...